Search
for
Sort by
Research 331–360 of 1000+
- Steroid-sparing effect of mycophenolate mofetil in the treatment of a subepidermal blistering autoimmune disease in a dog : clinical communication
- DEVELOPMENT OF A DESMOCOLLIN-3 ACTIVE MOUSE MODEL RECAPITULATING HUMAN ATYPICAL PEMPHIGUS
- Treatment of alopecia areata with squaric acid dibutylester
- 259 Scalp hair follicle dermal sheath fibroblasts express genes associated with promotion of skin integrity/wound healing and prevention of autoimmune responses in Recessive Dystrophic Epidermolysis Bullosa
- Issue Information - TOC
- Keratolysis in a patient with pemphigus vulgaris
- Non-scarring Alopecia in Pemphigus Foliaceus
- Localized pemphigus vulgaris on scalp: an atypical presentation.
- 1,314
- 568 Evaluating results of an interferon-γ release assay in patients with autoimmune skin disease on hydroxychloroquine
- Alopecia in Epidermolysis Bullosa
- Life before and beyond blistering: The role of collagen XVII in epidermal physiology
- 010 Development of a Desmocollin-3 Active Mouse Model Recapitulating Human Atypical Pemphigus
- A Novel In Vivo Active Pemphigus Model Targeting Desmoglein1 and Desmoglein3: A Tool Representing All Pemphigus Variants
- Mice lacking desmocollin 1 show epidermal fragility accompanied by barrier defects and abnormal differentiation
- Generalized atrophic benign epidermolysis bullosa.
- A case of pemphigus vulgaris developing after platelet-rich plasma treatment
- 571 Role of observation for excisionally biopsied moderately dysplastic nevi with positive histologic margins and risk of development of future melanoma
- 570 Examining cutaneous disease activity as an outcome measure for clinical trials in dermatomyositis
- Was the epidemic skin disease of 1891 due to acute arsenic poisoning?
- Concomitant acute alopecia and profound bone marrow suppression: An unusual manifestation of azathioprine toxicity
- Alopecia as a rare but distinct manifestation of pemphigus vulgaris
- Alopecia areata; combination therapy with isotretinoin (0.05%) gel and minoxidil (2%) solution
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Anhidrotic effect of intradermal injections of botulinum toxin—A comparison of different products and concentrations
- The most common pediatric and adult dermatology patient complaints in a month of the COVID‐19 pandemic in Turkey
- Cutaneous manifestations of systemic lupus erythematosus
- Medications
- Complications in Esthetic Surgery
- Preparation and Evaluation of Topical Formulation of Diphenylcyclopropenone for the Treatment of Alopecia Areata